The launch of artificial intelligence-powered imaging and mapping capabilities for electrophysiology, early momentum for a drug releasing system for bladder cancer treatment, and progress toward...
Johnson & Johnson’s MedTech segment saw its worldwide operational sales grow 5.4% year over year in 2025, reaching about $33.8 billion, the company said in...
Johnson & Johnson reportedly found that 10% to 15% of artificial intelligence use cases deliver 80% of the value. Get the Full Story Complete the...
Johnson & Johnson’s (J&J) MedTech arm displayed resilience in its second quarter, navigating inflationary headwinds while prioritizing innovation. The unit, a key driver for J&J,...
The integration of robotics is reshaping surgical procedures, promising enhanced precision, efficiency, and improved patient outcomes. Get the Full Story Complete the form to unlock...
Johnson & Johnson (J&J) has emphasized the pivotal role of medical technology (MedTech) in advancing healthcare. Get the Full Story Complete the form to unlock this...
Six months after parting ways with its consumer health unit, Kenvue, Johnson & Johnson has reported total sales of $21.4 billion for the last quarter of...
Riding high, Johnson & Johnson reported pharmaceutical sales worth $13.89 billion on Tuesday (Oct 17), a year-over-year growth exceeding 5%. Get the Full Story Complete...